Back to mobile site

Bio-Rad Labs (BIO) Q4 Revs Beat Views

February 27, 2018 4:26 PM EST

Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $2.32, which includes tax gains and does not compare to the analyst estimate of $1.26. Revenue for the quarter came in at $620.4 million versus the consensus estimate of $619.15 million.

For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings